imiquimod has been researched along with Lupus Erythematosus, Cutaneous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González Fernández, D; Requena López, S; Valdés Pineda, F | 1 |
Arjona-Aguilera, C; Báez-Perea, JM; Brandão, BJF; Jiménez-Gallo, D; Linares-Barrios, M | 1 |
Berger, TG; Farsani, TT; Maguiness, SM; Zedek, DC | 1 |
Burnett, TJ; English, JC; Ferris, LK | 1 |
4 other study(ies) available for imiquimod and Lupus Erythematosus, Cutaneous
Article | Year |
---|---|
Erythematous Lesion on the Nose.
Topics: Aged; Humans; Imiquimod; Interferon Inducers; Lupus Erythematosus, Cutaneous; Male; Nose | 2018 |
Imiquimod-induced cutaneous lupus erythematosus with antinuclear antibodies showing a homogenous pattern.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Antibodies, Antinuclear; Facial Dermatoses; Female; Humans; Imiquimod; Lupus Erythematosus, Cutaneous | 2017 |
Imiquimod-induced subacute cutaneous lupus erythematosus-like changes.
Topics: Aminoquinolines; Female; Humans; Imiquimod; Immunologic Factors; Lupus Erythematosus, Cutaneous; Middle Aged | 2015 |
Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Autoimmune Diseases; Female; Humans; Imiquimod; Keratosis, Actinic; Lupus Erythematosus, Cutaneous; Middle Aged; Retinitis; Severity of Illness Index | 2010 |